Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 50 of 50 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company 410 Medical Inc. | Activity: Research and Development | Company Description 410 Medical is developing technology for rapid infusion of fluids and blood products for hospital, transport and military healthcare providers, enabling clinicians to quickly and effectively resuscitate patients with shock and hypotension. | Location Research Triangle Park | |
Company Advanced Animal Diagnostics Inc. | Activity: Research and Development | Company Description Advanced Animal Diagnostics (AAD) develops and commercializes diagnostics to detect and manage disease states, reproductive, nutritional and overall health status of production animals. | Location Morrisville | |
Company AgBiome Inc. | Activity: Research and Development | Company Description AgBiome uses its proprietary GENESIS™ platform to capture diverse, unique microbes for agriculturally relevant applications, and screens them with industry-best assays for insect, disease, and nematode control. AgBiome also develops and sells crop protection solutions. | Location Research Triangle Park | |
Company Alcon Research LLC | Activity: Research and Development | Company Description Alcon discovers, develops and commercializes first-in-class therapies for the treatment of patients with glaucoma, dry eye, retinal diseases and other diseases of the eye. | Location Durham | |
Company Aurobindo Pharma USA Inc. | Activity: Research and Development | Company Description Aurobindo Pharma is a generic drug manufacturer. Aurobindo develops inhalation and dermatological products from the company's U.S. research and development headquarters in North Carolina. | Location Durham | |
Company BioMedomics Inc. | Activity: Research and Development | Company Description BioMedomics develops and manufactures point-of-care (POC) diagnostics in hematology oncology, virology, women’s health and dermatology. | Location Morrisville | |
Company BIOMILQ | Activity: Research and Development | Company Description BIOMILQ is a women-owned biotechnology start-up leveraging patented technology to produce functional human milk components for early-life nutrition products through cell culture technology. | Location Durham | |
Company BioResource International Inc. | Activity: Research and Development | Company Description BioResource International (BRI) designs, develops and manufactures unique enzymes that help poultry and swine producers optimize animal nutrition and gut health. | Location Durham | |
Company BioSkryb Corp. | Activity: Research and Development | Company Description BioSkryb's SkrybAmp technology is a new DNA amplification technology powered by Primary Template Directed Amplification (PTA). | Location Durham | |
Company BridgeBio Gene Therapy | Activity: Research and Development | Company Description BridgeBio Gene Therapy is developing a gene therapy for the treatment of a monogenic disease that presents in childhood. | Location Raleigh | |
Company Brii Biosciences Inc. | Activity: Research and Development | Company Description Brii Biosciences develops therapies focused on infectious diseases and central nervous system diseases where patients experience high levels of unmet medical needs, limited choice and significant social stigmas. | Location Durham | |
Company Cell Microsystems Inc. | Activity: Research and Development | Company Description Cell Microsystems develops, manufactures, and markets products for single cell workflows including CRISPR gene editing, stem cell research, organoid studies, cell line development and antibody discovery. | Location Durham | |
Company Chimerix Inc. | Activity: Research and Development | Company Description Chimerix discovers, develops and commercializes broad spectrum antivirals for the prevention and treatment of life-threatening viral infections. | Location Durham | |
Company Curie Co | Activity: Research and Development | Company Description Curie Co. is a synthetic biology company that creates safe, sustainably-derived ingredients through enzyme engineering. | Location Durham | |
Company Dermavant Sciences | Activity: Research and Development | Company Description Dermavant, a part of the Roivant family of companies, develops therapies for the treatment of skin diseases. | Location Morrisville | |
Company DMC Biotechnologies Inc. | Activity: Research and Development | Company Description DMC Biotechnologies sustainably produces bio-based chemicals. | Location Morrisville | |
Company Elo Life Systems Inc. | Activity: Research and Development | Company Description Elo Life Systems uses a platform of precision breeding technologies to produce crops with novel traits. | Location Durham | |
Company EpiCypher Inc. | Activity: Research and Development | Company Description EpiCypher develops and manufactures novel products and services for epigenetics and chromatin biology, focused on enabling drug discovery research and development. | Location Durham | |
Company Foundation Medicine Inc. | Activity: Research and Development | Company Description Foundation Medicine develops and provides clinical assays that provide a comprehensive genomic profile to identify molecular alterations in a patient's cancer and match them with targeted therapies and clinical trials. | Location Morrisville | |
Company G1 Therapeutics Inc. | Activity: Research and Development | Company Description G1 Therapeutics is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for those affected by cancer. | Location Research Triangle Park | |
Company GreenLight Biosciences Inc. | Activity: Research and Development | Company Description Greenlight Biosciences has developed a cell-free bioprocessing method for the low-cost production of RNA for use in research in vaccine development, vector control, pandemic preparation, crop management and crop pesticides. | Location Research Triangle Park | |
Company HemoSonics LLC | Activity: Research and Development | Company Description HemoSonics is developing an in vitro diagnostic platform that measures the evolving stiffness of forming blood clots within a consumable test cartridge. Its technology assists with the management of coagulation dysfunctions at the point of care. | Location Durham | |
Company Imugene Limited (Durham) | Activity: Research and Development | Company Description Imugene is a clinical stage immuno-oncology company developing treatments that seek to activate the immune system of cancer patients to identify and eradicate tumors. | Location Durham | |
Company Inceptor Bio LLC | Activity: Research and Development | Company Description Inceptor Bio develops next-generation cell therapy platforms, across multiple cell types, to cure cancers. Its site includes a manufacturing facility for production of its therapies. | Location Raleigh | |
Company Inivata Inc. | Activity: Research and Development | Company Description Inivata develops a noninvasive liquid biopsy diagnostic using the precision of circulating tumor DNA (ctDNA) analysis for improving cancer detection and assessing individual response to treatment. | Location Research Triangle Park | |
Company Jaguar Gene Therapy LLC (Analytical Development) | Activity: Research and Development | Company Description Jaguar Gene Therapy develops gene therapies for patients suffering from severe genetic diseases. The company's analytical development lab is located in Durham. | Location Durham | |
Company Jaguar Gene Therapy LLC (Process Sciences Lab) | Activity: Research and Development | Company Description Jaguar Gene Therapy develops gene therapies for patients suffering from severe genetic diseases. The company's process sciences lab is located in Cary. | Location Cary | |
Company Kowa Research Institute Inc. | Activity: Research and Development | Company Description Kowa Research Institute, a division of Kowa Company Ltd., develops therapeutic drugs for the treatment of cardio-metabolic diseases such as diabetes and atherosclerosis, pain and sensory organ disorders. | Location Morrisville | |
Company Leica Microsystems Inc. | Activity: Research and Development | Company Description Leica Microsystems manufactures microscopes and scientific instruments for the analysis of microstructures and nanostructures. Its Morrisville site develops optical coherence tomography imaging systems for ophthalmology preclinical research and surgery. | Location Morrisville | |
Company Life Edit Therapeutics | Activity: Research and Development | Company Description Life Edit Therapeutics, an ElevateBio company, identifies novel genome editing systems from a database of microbial genomes. These systems are then developed for use as human therapeutics, both in-house and through external partnerships. | Location Research Triangle Park | |
Company Liquidia Corporation | Activity: Research and Development | Company Description Liquidia Corporation develops and commercializes human therapeutics for the treatment of pulmonary arterial hypertension (PAH) and other applications using its proprietary particle engineering technology. | Location Morrisville | |
Company Locus Biosciences Inc. | Activity: Research and Development | Company Description Locus Biosciences is developing CRISPR-engineered bacteriophage (“crPhage”) products that kill target bacteria by irreversibly destroying their DNA while leaving the many species of beneficial bacteria in the body unharmed. | Location Morrisville | |
Company Nufarm Americas Inc. | Activity: Research and Development | Company Description Nufarm manufactures and markets insecticides, fungicides, plant growth regulators and herbicides. This site serves as Nufarm's primary research and development facility in the United States. | Location Morrisville | |
Company NuPulseCV | Activity: Research and Development | Company Description NuPulseCV is developing an implantable cardiovascular left ventricular assist device to treat people suffering from congestive heart failure. | Location Raleigh | |
Company Oerth Bio LLC | Activity: Research and Development | Company Description Oerth Bio is supporting crop protection, crop health, and healthy food by leveraging PROTAC® protein degrades, which work by harnessing the plant's own natural protein disposal system to degrade and remove unwanted proteins. | Location Durham | |
Company Parion Sciences Inc. | Activity: Research and Development | Company Description Parion Sciences develops therapies to treat defects of the innate mucosal defense system in respiratory diseases. | Location Durham | |
Company Reactive Biosciences Inc. | Activity: Research and Development | Company Description Reactive Biosciences uses a boron-based discovery platform to discover and develop new medicines. | Location Durham | |
Company Ribometrix Inc. | Activity: Research and Development | Company Description Ribometrix is developing a new class of small-molecule therapeutics that directly target and modulate the function of RNA to treat human diseases. | Location Durham | |
Company Shattuck Labs Inc. | Activity: Research and Development | Company Description Shattuck Labs is a preclinical-stage immunotherapy company focused on utilizing its proprietary ARC (Agonist Redirected Checkpoint) technology to develop novel treatments for use in cancer, inflammation and orphan disease. | Location Durham | |
Company Sipcam Agro USA Inc. | Activity: Research and Development | Company Description SipcamAdvan develops and manufactures herbicides, pesticides, fungicides and biocides. | Location Durham | |
Company Sobi (Durham) | Activity: Research and Development | Company Description Sobi develops treatments for orphan diseases with a focus on inflammation and genetic diseases. | Location Durham | |
Company Sumitomo Pharma America Inc. (Cary) | Activity: Research and Development | Company Description Sumitomo Pharma America develops regenerative therapeutics for rare diseases such as congenital athymia. | Location Cary | |
Company TG Therapeutics Inc. | Activity: Research and Development | Company Description TG Therapeutics is a commercial stage biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. | Location Morrisville | |
Company Tune Therapeutics | Activity: Research and Development | Company Description Tune Therapeutics develops novel cell and gene therapy products with their epigenome editing and gene regulation platform, TEMPO. | Location Durham | |
Company UPL (Cary) | Activity: Research and Development | Company Description UPL develops, manufactures and provides agricultural solutions, including biological, crop protection, seed treatment and post-harvest technologies covering the entire agricultural value chain. | Location Cary | |
Company UPL OpenAg Center (RTP) | Activity: Research and Development | Company Description UPL develops, manufactures and provides agricultural solutions across the agricultural value chain. The OpenAg Center contains climate-controlled greenhouses and laboratories and will partner with collaborating companies to develop resistance products. | Location Research Triangle Park | |
Company Verdesian Life Sciences LLC (Cary) | Activity: Research and Development | Company Description Verdesian Life Sciences develops agricultural products with a focus in plant health, inoculants, seed treatment and nutrition. | Location Cary | |
Company Verdesian Life Sciences LLC (RTP) | Activity: Research and Development | Company Description Verdesian Life Sciences' lab in RTP focuses on the exploration of emerging and disruptive technologies to improve plant nutrient use efficacy, agriculture productivity and environmental sustainability. | Location Research Triangle Park | |
Company Verona Pharma Inc. | Activity: Research and Development | Company Description Verona Pharma is a clinical stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of respiratory diseases such as chronic obstructive pulmonary fibrosis (COPD) and cystic fibrosis (CF). | Location Raleigh | |
Company Xilis Inc. | Activity: Research and Development | Company Description Xilis is developing microfluidic droplet-based patient-derived organoid (MDPDO) technology to guide precision therapy for cancer patients and accelerate drug discovery. | Location Durham |